NCT01940172: Study of Birinapant in Combination With Conatumumab in Subjects With Relapsed Ovarian Cancer |
|
|
| Completed | 1b | 27 | US | Birinapant, TL32711, Conatumumab | TetraLogic Pharmaceuticals | Relapsed Epithelial Ovarian Cancer, Relapsed Primary Peritoneal Cancer, Relapsed Fallopian Tube Cancer | 09/15 | 12/15 | | |
